Previous studies have served to demonstrate the molecular distinction between BCOR-CCNB3, CIC-DUX4, EWSR1-PATZ1, and EWSR1-NFATc2 fusion positive sarcomas and other traditional Ewing tumors7,26–28,30,42,43. This evidence concerns the gene NFATC2 and sarcoma.